All Events

Contributions of the Rochester Epidemiology Project to medicine and public health

Mon, 20 Aug 2018 16:52:20 GMT

Dr. Rocca is Professor of Epidemiology and Neurology and the Ralph S. and Beverley E. Caulkins Professor of Neurodegenerative Diseases Research at the Mayo Clinic in Rochester, Minnesota (USA). He is the Co-Director of the Rochester Epidemiology Project medical records-linkage system and Co-Director of the Mayo Clinic Specialized Center of Research on Sex Differences.

Dr. Rocca's research focuses on brain aging and on the etiology of common neurodegenerative diseases such as parkinsonism and dementia. He has recently focused his work on the effects of surgical menopause and estrogen on brain aging in women and on multimorbidity as a clinical marker of accelerated aging. He is also contributing to the emerging fields of dimorphic neurology and dimorphic medicine (impact of sex and gender on health and diseases).

Dr. St. Sauver is a Professor of Epidemiology in the Mayo Clinic School of Medicine in Rochester, Minnesota (USA). She received her MPH and PhD degrees in Epidemiology from the University of Michigan. After graduation, she joined Mayo Clinic as a Collaborative Scientist in 1999. She is an epidemiologic methodologist, with extensive experience in the design and conduct of observational research studies.

Her current research focuses on using the Rochester Epidemiology Project to understand the impact and outcomes of multiple chronic conditions at the population level. She is also a member of the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, with specific interest in community-based interventions to improve population health.

Hosted by: Jeffrey VanWormer, PhD

Note: This will be recorded and will be available via mediasite for live viewing:
http://mediasite.mfldclin.edu/Mediasite/Play/65c378484b40474fb3e6689eb9c191e81d

Light lunch will be offered at 11:45 a.m.
RSVP is appreciated to assist with ordering adequate food

Test Event Page Upcoming

Wed, 20 Jul 2016 13:58:31 GMT

Joshua Theisen - Programmer Analyst

Marshfield Clinic Research Foundation to cohost 22nd Annual HCSRN Conference

Wed, 10 Feb 2016 17:01:14 GMT

Marshfield Clinic Research Foundation (MCRF) will co-host the annual Health Care Systems Reseearch Network (HCSRN) conference along with Henry Ford Health System Research Centers (HFHS). The three-day conference will be held April 14-16, 2016 at the Hyatt Regency in Atlanta, GA. Robert Greenlee, PhD, MPH at MCRF and Lois Lamerato, PhD at HFHS are the Scientific Co-chairs. MCRF last cohosted the 14th annual meeting in 2008, in Minneapolis, MN.

The 2016 conference theme will be “Advancing Population Health: New Models and The Role of Research.” Visit www.HCSRNmeeting.org for more information about the conference

Global health at UW-Madison: A (air quality) to Z (zoonoses)

Thu, 02 Jul 2015 12:41:48 GMT

Christopher W. Olsen is Professor of Public Health in the Department of Pathobiological Sciences at the School of Veterinary Medicine and Associate Director for One Health of the Global Health Institute at the University of Wisconsin-Madison (Acting Director 2014-2015). He is also affiliated with the Master of Public Health degree program and a member of the MPH Advisory Committee; and, a member of the UW-Madison Morgridge Center for Public Service and Wisconsin Without Borders Advisory Committees, and the Division of International Studies Academic Planning Council.

Dr. Olsen received his DVM and PhD degrees from Cornell University and completed a post-doctoral fellowship at the UW-Madison. From 2007-2012 he served as Associate Dean for Academic Affairs in the School of Veterinary Medicine, and from September 2012 through June 2014, he served as Interim Vice Provost for Teaching and Learning for the UW-Madison.

Dr. Olsen’s research has focused on public health aspects of influenza in animals and the viral and host factors that control transmission of influenza viruses among people and animals. More generally, he has strong educational interests in zoonotic infectious diseases, in building bridges between the veterinary medical and human medical professions, and in promoting an cross-disciplinary One Health approach for global and public health. He has published more than 65 refereed research and educational journal articles, as well as numerous proceedings and book chapters. He is also the recipient of several faculty honors, including election to the University of Wisconsin-Madison Teaching Academy, and the School of Veterinary Medicine’s Norden Distinguished Teacher Award and Walter F. Renk Distinguished Professor Award.

Genetics and Molecular Insights into human sleep behavior

Wed, 20 May 2015 17:50:29 GMT

Dr. Louis Ptáček uses the tools of human genetics in studying patients with an impressive range of human phenotypes. He pioneered the field of “Channelopathies” which encompasses a large group of episodic/electrical disorders of muscle, heart, and brain. His earliest work focused a group of rare episodic muscle diseases he had proposed as models for more complex episodic/electrical disorders like cardiac arrhythmias and epilepsy. In another line of work motivated by a family with an interesting phenotype, he has now embarked into the challenging field of behavioral genetics. His group identified and characterized the first (only) Mendelian phenotype of the human circadian system. This autosomal dominant trait, familial advanced sleep phase (FASP), is manifest as a lifelong trait of extremely early sleep and early morning awakening (1–4 am). Ptáček and collaborator Ying-Hui Fu have gone on to characterize mutations in 5 genes that underlie the phenotype in ~10% of FASP families. Furthermore, they’ve gone on to model human FASP mutations in Drosophila and mice. In vitro and in vivo experiments focused on regions harboring the human mutations has led to novel insights in fine tuning of circadian period regulation by phosphorylation. He serves on a number editorial boards including Neurogenetics, eLife, and JCI. He is a member of the Institute of Medicine and the National Academy of Science.

*This presentation will be available for viewing online at your convenience via Marshfield Clinic’s MediaSite:
http://mediasite.mfldclin.edu/Mediasite/Play/95822c6b0fc54a85a849a1c8b3c6f0e71d

Inventor Recognition: Perspectives from the Frontline

Fri, 15 May 2015 13:51:21 GMT

Inventor Recognition: Perspectives from the Frontline

Tuesday, May 19th 12:00-1:00 pm – ML2A. A light lunch will be provided.

Developing any new technology involves identifying a problem faced by many and then creating a solution that elegantly addresses those needs. But this is really only the first step, moving a good idea from your mind, to paper, to a prototype, to a final product takes a lot more. Passion, persistence, and patience are all needed in equal measure to turn that great idea into an effective solution that others will reach for.

This week we will learn from the experience of inventors here at Marshfield Clinic. They will share how they identify the problems most in need of a solution, tips they have for creating a solution, and the skills that have helped them push those technologies along so they can eventually help others.

Please RSVP – 389.3430 or bushman.marsha@marshfieldclinic.org for lunch. Walk ins also welcome!

The goal of innovation in healthcare is to improve how the Clinic cares for patients, and to make those tools widely available. Contact or visit Applied Sciences in Laird Center for Medical Research – ML8 or visit its website: https://www.marshfieldclinic.org/applied-sciences.

Adapterama - Solving Practical Problems in Public Health with Next Generation DNA Sequencing

Tue, 17 Mar 2015 15:49:23 GMT

Dr. Glenn was a mid-western farm kid who studied agricultural biotechnology, natural resource management, conservation genetics, and evolutionary biology. He has been developing new DNA tools and collaborating widely since his PhD work using microsatellite DNA loci at the University of Maryland and the Smithsonian.

He worked at the University of Georgia's Savannah River Ecology Lab for 9 years before joining the Department of Environmental Health Science in the College of Public Health at UGA in 2008. He served as the faculty director of the Georgia Genomics Facility at UGA from 2008 through 2012. His research now focuses on developing novel sequence-capture techniques and next-generation DNA sequencing assays to improve public health.

Genetic Pleiotropy, Neuroimaging, and Dental Imaging: Identifying Genetic Risk, Endophenotypes, and Inflammatory Insult Leading to Alzheimer’s Disease

Wed, 04 Mar 2015 20:02:55 GMT

Gary Pack, PhD, is currently a NIDCR/NLM funded post-doctoral fellow in oral health informatics. He is jointly trained by the Computational and Informatics in Biology and Medicine program at the University of Wisconsin-Madison and the Institute for Oral and Systemic Health at the Marshfield Clinic Research Foundation. Dr. Pack is working under the mentorship of Dr. Amit Acharya and Dr. Mark Craven. After spending over 15 years in industry researching and designing computer hardware and software for parallel distributed systems he returned to university and earned his Ph.D. in Computer Science, Neuroimaging and statistics while doing cross-disciplinary work with the Waisman Laboratory for Brain Imaging and Behavior at the University of Wisconsin-Madison.

Objectives

Describe how the combination of genomics, periodontal data, dental and medical imaging could significantly impacts our ability to detect and better understand Alzheimer's disease (This is the primary focus of this talk)
Discuss what we mean by "clinical data"
Describe the importance and challenges of large scale studies and how clinical data can help
Explain why DICOM quality images are critical even if you never look at them with a DICOM compliant monitor

**At the conclusion of this presentation, participants may receive up to 1 continuing education credit hour for their professional certification or license renewal. The presentation is AGD PACE certified, so members of AGD may receive their credit by bringing their AGD member number. Please sign-in and include your email address & AGD-PACE Number.

Target Audience

This activity is intended for dentists, dental hygienists and other allied health professionals. Topics chosen have appeal and applicability for providers in a variety of practice environments.

This presentation will available for viewing online at your convenience via Marshfield Clinic’s MediaSite:

http://mediasite.mfldclin.edu/Mediasite/Play/1a25140882224d608d95d08848e1246b1d

Biotech CEO Tells All: Creating Marketable Technologies

Tue, 24 Mar 2015 18:30:56 GMT

Medical technology encompasses a wide range of health care products used to diagnose, monitor, or treat the diseases and other conditions known to affect humans. The bar for demonstrating differentiated clinical and economic value for medical technologies is rising. The new “value bar” forces med tech companies to rethink how they can effectively create a product that will meet this ever-increasing set of expectations.

In this month’s Inventor Forum, we will hear from Paul Radspinner, founder, president, and CEO of FluGen, a Madison-based biotech company focusing on developing an efficacious vaccine that shows promise as a “universal” influenza vaccine. Radspinner will share what it takes to have a technology ready to enter the market space through licensing or start-up, using FluGen as the case study.

Please RSVP – 9.3430 or bushman.marsha@marshfieldclinic.org for lunch. Walk ins also welcome! Presentation will also be available on mediasite:

http://mediasite.mfldclin.edu/Mediasite/Play/d37a52f1d2004a99946f997ad55703b71d

Join us for our Monthly Inventor Forums at noon in ML2A (Laird Building North around the left corner from BIRC/Applied Sciences offices), including:

• April 21 – Alliance Partnership: Creating Collaboration Across the Ecosystem.

• May 19 – Inventor Recognition: Perspectives from the Frontline.

https://www.marshfieldclinic.org/applied-sciences

The Molecular Architecture of Mitochondrial Energy Metabolism

Thu, 22 Jan 2015 20:54:52 GMT

Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his degree in Medicine and Genetics from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. He completed his pediatric residency at the University of Colorado Health Science Center, and his postdoctoral fellowship in Human Genetic and Pediatrics at Yale University School of Medicine in New Haven, Connecticut. Before assuming his current position in Pittsburgh, Dr. Vockley was Chair of Medical Genetics in the Mayo Clinic School of Medicine. Dr. Vockley is internationally recognized as a leader in the field of inborn errors of metabolism. His current research focuses on the molecular architecture of mitochondrial energy metabolism. Dr. Vockley has served on numerous national and international scientific boards including the Advisory Committee (to the Secretary of Health and Human Services) on Heritable Disorders in Newborns and Children where he was chair of the technology committee. He is co-chair of the International Network on Fatty Acid Oxidation Research and Therapy (INFORM). He also serves as chair of the Pennsylvania State Newborn Screening Advisory Committee and the American College of Medical Genetics Therapeutics Committee. He is a past president of the International Organizing Committee for the International Congress on Inborn Errors of Metabolism and the Society for the Inherited Metabolic Disorders (SIMD), and co-founder and editor of the North American Metabolic Academy.

http://mediasite.mfldclin.edu/Mediasite/Play/41fb2cdcb2054d63aff962df39178bf21d

Research Foundation: Bench to Discovery Opportunities

Tue, 10 Feb 2015 20:15:51 GMT

Please join us for the next in our series of Monthly Inventor Forums

Research Foundation: Bench to Discovery Opportunities

Tuesday, Feb. 17 – 12:00 pm – 1:00 pm – ML2A (Laird North, left hall from BIRC). A light lunch will be provided.

How can you bring an idea that may help patient care to life? Such ideas happen all the time in healthcare, but many are not acted upon, whether due to a lack of knowledge of the process or a lack of resources. Join us on Feb 17^th, to discuss how Applied Sciences and the Marshfield Clinic Research Foundation work together to develop the strategies needed to develop an idea into a practical discovery.

Please RSVP – 9.3430 or Barwick.marsha@marshfieldclinic.org for lunch. Walk ins also welcome!

Join us for our Monthly Inventor Forums at noon in ML2A (Laird Building North around the left corner from BIRC/Applied Sciences offices), including:

• March 31 – Finance & Innovation: Identifying Funding Sources and Innovating for the Bottom Line.

• April 21 – Alliance Partnership: Creating Collaboration Across the Ecosystem.

• May 19 – Inventor Recognition: Perspectives from the Frontline.

http://mediasite.mfldclin.edu/Mediasite/Play/7309dc185d98483eaa276463ccd749421d

Inventor Forum - Global Impact: Delivering Innovations to Patients via Licenses or Start-Ups

Mon, 24 Nov 2014 19:34:21 GMT

Global Impact: Delivering Innovations to Patients via Licenses or Start-Ups

Tuesday, January 27 - 12:00 pm – 1:00 pm – ML2A. A light lunch will be provided.

Marshfield Clinic’s research and development (R&D) efforts are focused on translating our scientific understandings into new treatments. We care passionately about creating more effective, more efficient and safer healthcare through innovation. Applied Sciences can make this a reality by providing a clear and easy pathway for anyone — physicians, nurses, healthcare clinicians, and staff — to submit a medical invention idea for potential commercialization. We then harness the power of that invention by licensing technology to experts in chosen fields. Come learn about how the process can work for you.

Please RSVP – 389.3430 or Barwick.marsha@marshfieldclinic.org for lunch. Walk ins also welcome!

Join us for our Monthly Inventor Forums at noon in ML2A, including:

Feb. 17 – Research Foundation: Bench to Discovery Opportunities.
Mar. 31 – Finance & Innovation: Identifying Funding Sources and Innovating for the Bottom Line.
Apr. 21 – Alliance Partnership: Creating Collaboration Across the Ecosystem.
May 19 – Inventor Recognition: Perspectives from the Frontline.

The goal of innovation in healthcare is to improve how the Clinic cares for patients, and to make those tools widely available. Contact or visit Applied Sciences in Laird Center for Medical Research – ML8 or visit its website at https://www.marshfieldclinic.org/applied-sciences.

Genomics, Dental and Medical Imaging: Pleiotrophic Models for the Prediction of Alzheimer’s Disease

Fri, 23 Jan 2015 14:19:14 GMT

Genomics, Dental and Medical Imaging: Pleiotrophic Models for the Prediction of Alzheimer’s Disease

Abstract:

In the last twenty years it has become increasingly apparent that oral and systemic health are deeply intertwined, especially in the case of diseases that are influenced by inflammatory processes. In fact, both Alzheimer's disease and degenerative disease of the oral cavity have been associated with genes that control the production of cytokines. Yet, at least in part because of the challenges of dealing with very high dimensional genetic data, different studies often have provided contradictory results as to which alleles are involved. Since both of these disease processes are related to inflammation, it seems likely that a common set of alleles could be involved. Such a situation is known as pleiotrophy.

Pleiotrophy assumes that a specific set of alleles influence the expression of disparate phenotypes. In this case, the phenotypes are Alzheimer's and periodontal disease. Neuroimaging, along with other clinical indicators, has been used to identify and quantify the changes in the brain associated with Alzheimer's. We are proposing dental imaging and periodontal data to quantify the effects of inflammation on the maxillofacial region.

The Marshfield Clinic and the Marshfield Clinic Research Foundation have collected genomic data on approximately 9000 patients. Additionally, the Marshfield Clinic has imaging data on many of their patients that includes some brain imaging. Finally, the Institute for Oral and Systemic Health has collected imaging and periodontal measures for 103,000 patients, many of whom have also had their genome sequenced.

In this talk, we present some of the challenges and barriers to making use of these data and give some sense of our modeling approach.

Speaker Information:

Gary Pack, PhD, is currently a NIDCR/NLM funded post-doctoral fellow in oral health informatics. He is jointly trained by the Computational and Informatics in Biology and Medicine program at the University of Wisconsin-Madison and the Institute for Oral and Systemic Health at the Marshfield Clinic Research Foundation. Dr. Pack is working under the mentorship of Dr. Amit Acharya and Dr. Mark Craven. After spending over 15 years in industry researching and designing computer hardware and software for parallel distributed systems, he returned to university and earned his PhD in Computer Science, Neuroimaging and Statistics, while doing cross-disciplinary work with the Waisman Laboratory for Brain Imaging and Behavior at the University of Wisconsin-Madison.

Changing Diagnostic Landscape of Evidence-Based, Precision Medicine

Tue, 02 Dec 2014 18:01:44 GMT

John Sninsky, PhD, was the Vice President of Discovery Research at Celera (2000-2011). The Discovery Research group encompassed teams of scientists who worked in: cardiometabolic disease and cancer, a highthroughput genotyping and expression facility, biostatistics, and computational biology/bioinformatics. His primary focus was the application of genetic and genomic tools to identify and develop laboratory developed tests for CLIA setting and in vitro diagnostic products for diagnostic/prognostic and pharmacogenomic biomarkers. Dr. Sninsky is the author of numerous scientific papers including methods in molecular biology, lipid sub-fractionation, application of the polymerase chain reaction (PCR) to virology and cancer, and genome-wide genetic association studies for multiple common, complex diseases. With the acquisition of Celera by Quest Diagnostics in 2011, Dr. Sninsky accepted additional responsibilities; for example, he oversaw company-wide bioinformatics for Quest Diagnostics and served as the site head for Science & Innovation in Alameda, California (2011-2014).

Among Dr. Sninsky’s past awards are the Centers for Disease Control Charles C. Shepherd Science Award (1988), the Pan American Society for Clinical Virology Award (1992) and the Hoffmann-La Roche R & D Prize in 1997 for his efforts in applying PCR to virology and developing assays for measuring viral load in individuals with (HIV) AIDS.

Dr. Sninsky was a recipient of the Purdue University Distinguished Alumni Award in 2001, and served on the Department of Biological Sciences Alumni Advisory Committee (2005-2007) before joining the Dean of College of Science Leadership Council in 2007. In addition, Dr. Sninsky is a member of the scientific advisory committee for the Charles R. Bronfman Institute for Personalized Medicine at Mount Sinai School of Medicine, chairs the scientific advisory panel for the Professional Science Masters (PSM) Program with an emphasis in Biotechnology and Stem Cell Science at San Francisco State University (SFSU), and is a member of Stanford University SPARK program which facilitates communication between academia and industry to accelerate translational medicine. More recently, Dr. Sninsky was added as a diagnostics advisor to the Clinical & Translational Science Institute (CTSI) at University California, San Francisco and joined the Indiana University Institute for Personalized Medicine formed from the schools of medicine, informatics, and nursing.

Among Dr. Sninsky’s professional society memberships are American Association for the Advancement of Science, Association of Molecular Pathologists, American Society Human Genetics, American College Medical Genetics, American Association Cancer Research and American Association for the Study of Liver Disease. Dr. Sninsky received a bachelor’s degree in biology from Bates College and a Ph.D. in biology from

Purdue University. He was a postdoctoral fellow in Genetics and Medicine at Stanford University School of Medicine with Stanley N. Cohen. Dr. Sninsky was on the faculty at Albert Einstein College of Medicine (AECOM) in the Department of Microbiology and Immunology with a joint appointment in the Department of Molecular Biology. He was a member of the AECOM Liver and Cancer Centers. From 1984 to 1991, he worked at Cetus Corporation where he was responsible for the immunoassay and molecular diagnostics programs.

From 1991 to 1998, John was the Senior Director of Research at Roche Molecular Systems. His team of scientists devised PCR diagnostic assays for many infectious pathogens as well as for genetic diseases and cancer. In 1998, he was promoted to Vice President, Discovery Research as well as Vice President, Roche Genetics, an initiative that coordinated the genetic and genomic efforts between the pharmaceutical and diagnostics divisions. Dr. Sninsky joined Celera in 2000.

http://mediasite.mfldclin.edu/Mediasite/Play/6bfe92bacdf14077a9694d05a2018b461d

Inventor Forum - Planting Your Flag: The Various Strategies of Securing Intellectual Property

Mon, 24 Nov 2014 17:57:54 GMT

Planting your Flag: The Various Strategies of Securing Intellectual Property

Tuesday, December 16 - 12:00 pm – 1:00 pm – ML2A. A light lunch will be provided.

Defending intellectual property through patents and other tactics creates the legal underpinning necessary to safeguard your ideas and make sure other companies pay for use of those ideas. However, building a strong IP defense is anything but simple. Learn what Applied Sciences can do to help you protect your valuable ideas and secure the rights entitled to you through your research, development, and discovery.

Please RSVP – 389.3430 or Barwick.marsha@marshfieldclinic.org for lunch. Walk ins also welcome!

Join us for our Monthly Inventor Forums at noon in ML2A, including:

Jan. 27 – Global Impact: Delivering Innovations to Patients via Licenses or Start-Ups.
Feb. 17 – Research Foundation: Bench to Discovery Opportunities.
Mar. 31 – Finance & Innovation: Identifying Funding Sources and Innovating for the Bottom Line.
Apr. 21 – Alliance Partnership: Creating Collaboration Across the Ecosystem.
May 19 – Inventor Recognition: Perspectives from the Frontline.

The goal of innovation in healthcare is to improve how the Clinic cares for patients, and to make those tools widely available. Contact or visit Applied Sciences in Laird Center for Medical Research – ML8 or visit its website at https://www.marshfieldclinic.org/applied-sciences.

From Bench to Bedside and Back with Cholesterol Synthesis Disorders

Fri, 19 Dec 2014 19:25:19 GMT

Robert D. Steiner, MD is Executive Director, Marshfield Clinic Research Foundation, Chief Science Officer Marshfield Clinic, and Executive Associate Director, University of Wisconsin Institute for Clinical and Translational Research (ICTR). He is also Visiting Professor, University of Wisconsin School of Medicine and Public Health. Steiner was formerly (prior to 4/2013) Credit Unions for Kids Professor of Pediatric Research, Professor of Pediatrics and Molecular & Medical Genetics, and Vice Chair for Research in Pediatrics at Doernbecher Children’s Hospital and the Institute for Developmental Disabilities, Oregon Health & Science University (OHSU) in Portland, Oregon. Steiner earned his BS with Honors from the University of Wisconsin, followed by MD from the University of Wisconsin School of Medicine. He subsequently completed residency in pediatrics at Cincinnati Children’s Hospital Medical Center and fellowship in medical genetics at the University of Washington and Seattle Children’s Hospital. Dr. Steiner is board certified in pediatrics, clinical genetics, and clinical biochemical genetics.

Dr. Steiner is an active clinician in the field of medical genetics, with specific interests in inherited metabolic diseases, cholesterol disorders, metabolic bone diseases, and newborn screening. He has been listed in Best Doctors in America 2009-13 Inclusive, and Portland’s Top Doctors, Portland Monthly Magazine, 2012. In addition, he is an accomplished researcher, having served as the Principal Investigator for more than a dozen clinical trials and clinical research studies on Smith-Lemli-Opitz Syndrome (SLOS), Osteogenesis Imperfecta, Phenylketonura, Lysosomal Storage Diseases, and others. His research on SLOS and related disorders is funded by the National Institutes of Health, in part by an award from the NIH Rare Disease Clinical Research Network (RDCRN). Steiner has authored over 125 peer-reviewed original research articles, and more than 70 letters, reviews, book sections, and book chapters, on genetic diseases and related topics. He currently serves as an editorial board member of the Journal of Inherited Metabolic Disease and New Horizons in Translational Medicine, and is presently the Deputy Editor for Genetics in Medicine.

Dr. Steiner is a member of several professional societies, including the American Society of Human Genetics, American College of Medical Genetics, Society for Inherited Metabolic Disorders, and the Society for the Study of Inborn Errors of Metabolism. He’s an elected member of the Society for Pediatric Research. Dr. Steiner has had numerous appointments on national committees and advisory boards including serving as Chair of the American College of Medical Genetics working group on Pompe disease, as a Standing Committee member of the Newborn Screening Translational Research Network, and as a member of the American College of Medical Genetics Therapeutics Committee. He is an active supporter of several patient advocacy groups including service on the SLOS Foundation Medical Advisory Board, and Batten Disease Spport and Research Association Medical/Scientific Advisory Board. Steiner was an elected member of the executive committee for the Section on Genetics and Birth Defects of the American Academy of Pediatrics. Recently, he was elected a member of the American College of Medical Genetics Board of Directors, term starting in 2013. He teaches in the SIMD North American Metabolic Academy (NAMA). Finally, he was a member of the Institute of Medicine (IOM) Committee that published recommendations on Accelerating Rare Diseases Research and Orphan Product Development.

View this presentation here.

Inventor Forum - Invention Disclosure: Paper to Pen, Best Laid Out Ideas

Mon, 17 Nov 2014 17:41:24 GMT

Please join us for the next in our series of Innovation Forms:

Invention Disclosure: Paper to Pen, Best Laid Out Ideas

Tuesday, November 18 – 12:00 pm – 1:00 pm – ML2A. A light lunch will be provided.

Invention disclosure is more than the simple completion of a standard form. It includes a complete description of something you have thought through as a solution to a problem, and maybe even created a draft of. Applied Sciences will work with you on your device or discovery to be sure it is novel and nonobvious given in a manner that anyone of ordinary skill in the particular art could reproduce the invention. The disclosure represents the first official recording of the invention and can establish an irrefutable date and scope of the invention. In this forum, we will explain the nuts and bolts of invention disclosures (as well as some of the nuances), beginning with the responsibility of inventors to disclose inventions before they are made public and ending with the use of disclosures to create defensible patents.

Please RSVP – 389.3430 or Barwick.marsha@marshfieldclinic.org for lunch. Walk ins also welcome!

Join us for our Monthly Inventor Forums at noon in ML2A, including:

Dec. 16 – Planting your Flag: The Various Strategies of Securing Intellectual Property.
Jan. 27 – Global Impact: Delivering Innovations to Patients via Licenses or Start-Ups.
Feb. 17 – Research Foundation: Bench to Discovery Opportunities.
Mar. 31 – Finance & Innovation: Identifying Funding Sources and Innovating for the Bottom Line.
Apr. 21 – Alliance Partnership: Creating Collaboration Across the Ecosystem.
May 19 – Inventor Recognition: Perspectives from the Frontline.

The goal of innovation in healthcare is to improve how the Clinic cares for patients, and to make those tools widely available. Contact or visit Applied Sciences in Laird Center for Medical Research – ML8 or visit its website at https://www.marshfieldclinic.org/applied-sciences.

Objectively Measuring Physical Activity and Sleep in Health and Disease

Wed, 05 Nov 2014 20:51:47 GMT

Objectively Measuring Physical Activity and Sleep in Health and Disease

13th Annual Fall Cancer Symposium

Tue, 09 Sep 2014 17:25:18 GMT

This conference is designed for individuals who are involved in cancer treatment and education of cancer patients and their families: oncology physicians, primary care physicians, oncology nurses, nurse practitioners, clinical research associates, health educators, social workers, psychologists, chaplains and other interested health care professionals involved in cancer care. Patients, caregivers and community members are also encouraged to attend.

Shared Goals and Clear Roles: Coordinating the Cancer Journey

Mindy Gribble, RN, HNB-BC
Wings Survivorship Program Coordinator, Marshfield Clinic Oncology/Hematology

William Hocking, MD
Marshfield Clinic Oncology/Hematology

Learning Organizations and Learning Communities

Fri, 24 Oct 2014 19:15:39 GMT

Andrew F. Nelson is Executive Director of the HealthPartners Institute for Education and Research and Vice President of HealthPartners. Mr. Nelson has provided leadership for this nonprofit, medical/health care research organization since 1990. He also serves as a corporate officer for HealthPartners, Inc. HealthPartners is an integrated health delivery system servicing over one-million people in Minnesota. HealthPartners Institute for Education and Research conducts over two hundred laboratory, clinical and health services research projects annually, through 143 full-time staff, 27 full-time career researchers, joined by more than 40 clinical researchers conducting a broad array of basic, clinical, and health services research. More than 150 people from the larger HealthPartners organization also contribute to or conduct research under the Institute.

Prior to the HealthPartners Institute position, he was executive director of the Day Community Program at the University of Minnesota’s day-treatment program for emotionally and behaviorally disturbed adolescents. He has led or participated in numerous grants and contracts, authored or contributed to many publications and presentations.

Mr. Nelson is a founding member of the HMO Research Network, 19 research organizations providing public domain research involving over 12 million people served by our sponsored health care delivery organizations. He serves on a wide range of professional and community Boards.